Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A once-weekly formulation was later approved for diabetes in 2012
It is typically reversible with dose reduction but should not be ignored
Many studies have consistently reported that several GLP-1RAs exert inhibitory effects on plaque formation, development, and rupture (Tashiro et al., 2014
Long term effects are not known as it is only being used since past 5-6 years
Access in SA South Africas Department of Health does not currently recommend any GLP-1 agonists for the diabetes or obesity treatment, and these medicines are not available in the public healthcare sector
As tolerated, increase the dose until you have reached the recommended normal or advanced guidelines
US$ 26.92
US$ 26.19
US$ 27.97
US$ 27.26
US$ 29.73
